Aralez Pharmaceuticals Inc.
SEC CIK 1660719 · ARLZ · last insider filing 2018-06-06
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Kirsch Arthur S | Director | filed 2016 - 2017 |
| Aryeh Jason | Director | filed 2016 - 2017 |
| Rudnick Seth | Director | filed 2016 - 2017 |
| LEE Kenneth B JR | Director | filed 2016 - 2017 |
| Adams Adrian | Director · Chief Executive Officer | filed 2016 - 2017 |
| Thrasher Francis Martin | Director | filed 2016 - 2017 |
| Fowler Neal Franklin | Director | filed 2016 - 2017 |
| Harris Robert Paul | Director | filed 2016 - 2017 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Koven Andrew I | President & Chief Business Off | filed 2016 - 2018 |
| Tursi James Patrick | Chief Medical Officer | filed 2016 - 2018 |
| Glickman Mark A | Chief Commercial officer | filed 2016 - 2018 |
| Trachtenberg Eric | General Counsel, COO & Sect | filed 2016 - 2018 |
| Kaseta Michael | Interim CFO | filed 2017 - 2018 |
| Charles Scott J | Chief Financial Officer | filed 2016 - 2017 |
| Armstrong Jennifer Lou | EVP HR and Administration | filed 2016 - 2017 |
| Barnhardt John E | VP, Finance and Administration | filed 2016 - 2016 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.